Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Tero Kontiokari a Department of Pediatrics, University of
Oulu, Oulu, Fin-90220, Finland, b Finnish Student Health Service, Oulu,
Finland, c Laboratory of Clinical Microbiology, Oulu University Hospital,
Oulu, Fin-90220, Finland
Correspondence to: T Kontiokari tero.kontiokari{at}oulu.fi
| |
Abstract |
|---|
|
|
|---|
Objective:
To determine whether recurrences of urinary tract infection can be prevented with cranberry-lingonberry juice or
with Lactobacillus GG drink.
Design:
Open, randomised controlled 12 month follow up trial.
Setting:
Health centres for university students and staff of university hospital.
Participants:
150 women with urinary tract infection
caused by Escherichia coli randomly allocated into three groups.
Interventions:
50 ml of cranberry-lingonberry juice
concentrate daily for six months or 100 ml of lactobacillus drink
five days a week for one year, or no intervention.
Main outcome measure:
First recurrence of symptomatic
urinary tract infection, defined as bacterial growth
105
colony forming units/ml in a clean voided midstream urine specimen.
Results:
The cumulative rate of first recurrence of urinary tract infection during the 12 month follow up differed significantly between the groups (P=0.048). At six months, eight (16%)
women in the cranberry group, 19 (39%) in the lactobacillus group, and
18 (36%) in the control group had had at least one recurrence. This is
a 20% reduction in absolute risk in the cranberry group compared with
the control group (95% confidence interval 3% to 36%, P=0.023,
number needed to treat=5, 95% confidence interval 3 to 34).
Conclusion:
Regular drinking of cranberry juice but
not lactobacillus seems to reduce the recurrence of urinary tract infection.
|
What is already known on this topic
What this study adds
|
| |
Introduction |
|---|
|
|
|---|
Up to 60% of women have a urinary tract infection at some point in their life.1 At least a third of women with urinary tract infection will experience a recurrence during the following year, with recurrence being most common in the age groups 25-9 and over 55 years.2
The bacteria causing urinary tract infection arise from the stools.
Dietary changes can alter the balance of faecal bacteria.3 Vaccinium berries and products containing lactobacilli have been shown
to act against the coliform bacteria that cause most urinary tract
infections.
4 5
Cranberry juice prevents bacteriuria in
elderly women,6 and locally administered lactobacilli
prevent recurrences of urinary tract infections.7 To
evaluate whether these products given orally are effective in
preventing symptomatic recurrences of urinary tract infection we
conducted an open, randomised, controlled trial.
| |
Participants and methods |
|---|
|
|
|---|
Study population and design
We recruited women during 1993-7 from the Finnish student health
service at the University of Oulu and the occupational health centre
for the staff of Oulu University Hospital. Women who had a urinary
tract infection caused by Escherichia coli
(
105 colony forming units/ml in clean voided
midstream urine) and were not taking antimicrobial prophylaxis were
invited to participate. After giving informed consent, they were
randomly allocated into three groups.
105 cfu/ml as the criterion for
infection. The laboratory staff were unaware as to which of the
treatment groups participants belonged.
We followed perianal and urethral colonisation with lactobacilli by
taking swab samples at the start and at three and 12 months. The
protocol was evaluated and approved by the ethics committee of the
medical faculty of the University of Oulu.
Sample size
We calculated the sample size based on the assumption that at
least 30% of women will experience a recurrence of urinary tract
infection within a year.2 We considered a reduction in
recurrences to 10% as clinically important. To detect such a reduction
with a two tailed
of 0.05 and a power of 80%, we needed 70 women
in each group. Recruitment had to be stopped prematurely because the
cranberry juice supplier stopped producing the juice.
Statistical methods
We used the Kaplan-Meier method to analyse the cumulative first
recurrence and the Breslow test to assess the differences in
occurrences at the end of the study. We calculated the incidence
density by adding the total number of episodes of urinary tract
infection and the time at risk in each group and then calculating the
rate of episodes per person year at risk.
| |
Results |
|---|
|
|
|---|
A total of 150 women gave their informed consent and were randomly allocated into three groups, 50 in each. One subject in the lactobacillus group who was taking postcoital antimicrobials was excluded from the analysis. The groups were similar in their baseline characteristics with regard to the risk of urinary tract infection (table). Only 13 women dropped out of the study, usually because of moving away.
|
During the six months, eight (16%) women in the cranberry group, 19 (39%) in the lactobacillus group, and 18 (36%) in the control group had at least one episode of urinary tract infection. This is a 20% reduction in absolute risk in the cranberry group compared with the control group (95% confidence interval 3% to 36%, P=0.023, number needed to treat=5, 95% confidence interval 3 to 34). The numbers who had had a recurrence at 12 months were 12, 21, and 19 in the cranberry, lactobacillus, and control groups respectively. The cumulative first recurrence of urinary tract infection differed significantly between the groups throughout the trial (P=0.048 at 12 months; figure). Recurrence during the study period was significantly lower in the cranberry group than in the control group (P=0.014 at 6 months, P=0.052 at 12 months).
|
There were 98 episodes of urinary tract infection altogether during follow up, of which 21 (21%) occurred in the cranberry group, 39 (40%) in the lactobacillus group, and 38 (39%) in the control group. The difference of 0.36 in incidence densities per person year between the cranberry and control group was significant (95% confidence interval 0.03 to 0.68).
The causative bacterium was E coli in 80% of the episodes. The proportion of episodes caused by E coli did not differ between the study groups. The number of women with perianal or urethral cultures positive for lactobacilli at any time during follow up was similar in all three groups; there were 32 (71%) in the cranberry group, 33 (67%) in the lactobacillus group, and 37 (82%) in the control group.
No adverse events were reported except occasional complaints about the
bitter taste of the cranberry juice.
| |
Discussion |
|---|
|
|
|---|
Our study confirms the common belief that symptomatic recurrences of urinary tract infection can be prevented with cranberry juice. In a recent review, the previous evidence for this was found inconclusive,8 although earlier reports had suggested a beneficial effect.9 The daily consumption of 300 ml of cranberry juice reduced bacteriuria in postmenopausal women, but no beneficial effect was found among children with neurogenic bladder. 6 10 Our study population represented a typical group of women at risk of recurrences of urinary tract infection. Such women are also the most willing and able to take preventive measures. We thus believe that our result is of both medical and practical importance.
In the United States, over 11 million women each year receive antimicrobials for urinary tract infection, costing over $1.6bn (£1100m).1 Antimicrobial treatment and prophylaxis has resulted in increasing resistance to antimicrobials among uropathogenic bacteria.11 Cranberry juice provides an alternative tool for prevention of urinary tract infection that could result in decreased use of antimicrobials.
Action of cranberry juice
The berries of Vaccinium species such as
cranberries and blueberries contain condensed tannins called
proanthocyanidins. These can prevent the expression of the P fimbriae
of E coli,4 which is the most common
uropathogenic bacterium; its P fimbriae are thought to be the most
important virulence factor in causing urinary tract infection. The
blocking of fimbrial adhesion by cranberry juice prevents E
coli and other gram negative bacteria from colonising the
uroepithelial cells.12-14 The juice may help to
prevent urinary tract infection either by selecting less adhesive bacterial strains in the stool or by directly preventing E
coli from adhering to uroepithelial cells, or by both of
these mechanisms.
15 16
Our finding of no increase in
recurrences after stopping cranberry prophylaxis supports the theory of
bacterial selection in the stool.
Lactobacillus
The lactobacillus drink had no effect on urinary tract
infection, possibly because we were unable to induce lactobacilli colonisation of the periurethral area. Lactobacilli have been shown to
colonise the human intestine at doses of 108-10
cfu/day and to replace other bacterial species, especially coliform bacteria.
5 17
Consumption five times a week may have been too infrequent. Intravaginal administration of lactobacilli has been
found to reduce the number of coliform bacteria in the periurethral area and the number of urinary tract infections after antimicrobial treatment.7 In postmenopausal women, vaginal lactobacilli
are replaced by enterobacteriaceae, increasing the risk of bacteriuria. This process can be reversed by intravaginal administration of oestriol.18
Validity
We had to stop our trial prematurely because the manufacturer of
the cranberry juice stopped producing it. However, the difference in
the occurrence of urinary tract infection between the cranberry and
control group was clear and constant even in this limited sample size.
A compliance follow up sheet was returned by only half of the subjects,
but the reports suggested that the compliance was good and the
stratified analysis showed no differences between the subjects who did
and did not return the follow up sheet.
| |
Acknowledgments |
|---|
We thank Marli and Valio for providing the study products and Eeva-Liisa Lesonen and Tuulikki Ryhänen for recruiting women to the trial at the staff health centre.
Contributors: MU initiated and coordinated the formulation of the primary study hypothesis. TK participated in the formulation of study hypothesis and design and was responsible for coordinating the collection and entry of data. KS was responsible for the recruitment of the study subjects in the Finnish student health service. MU, MN, KS, and TK discussed core ideas, designed the study protocol, and participated in the data analysis, interpretation of the results, and writing the paper. TP was responsible for the statistical analysis, participated in the interpretation of the results, and contributed to the design and writing the paper. MK was responsible for the quality of the laboratory analysis and contributed to the design and the writing of the paper. MU and TK are guarantors of the content of the paper.
| |
Footnotes |
|---|
Funding: Emil Aaltonen, Juho Vainio, and Alma and K A Snellman Foundations.
Competing interests: None declared.
The full version of this paper is
available on the BMJ's website
| |
References |
|---|
|
|
|---|
| 1. |
Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD.
Urinary tract infection: self-reported incidence and associated costs.
Ann Epidemiol
2000;
10:
509-515 |
| 2. |
Ikäheimo R, Siitonen A, Heiskanen T, Kärkkäinen U, Kuosmanen P, Lipponen P, et al.
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women.
Clin Infect Dis
1996;
22:
91-99 |
| 3. |
Gibson GR.
Dietary modulation of the human gut microflora using prebiotics.
Br J Nutr
1998;
80:
209-212 |
| 4. |
Howell AB, Vorsa N, Der Marderosian A, Foo LY.
Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries.
N Engl J Med
1998;
339:
1085-1086 |
| 5. |
Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW.
Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments.
Infect Immun
1985;
47:
84-89 |
| 6. |
Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA.
Reduction of bacteriuria and pyuria after ingestion of cranberry juice.
JAMA
1994;
271:
751-754 |
| 7. |
Reid G, Bruce AW, Taylor M.
Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.
Clin Ther
1992;
14:
11-16 |
| 8. | Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2000;2:CD001321. |
| 9. |
Blatherwick NR.
The specific role of foods in relation to the composition of the urine.
Arch Intern Med
1914;
14:
409-450 |
| 10. |
Schlager TA, Anderson S, Trudell J, Hendley JO.
Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization.
J Pediatr
1999;
135:
698-702 |
| 11. |
Gupta K, Scholes D, Stamm WE.
Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
JAMA
1999;
281:
736-738 |
| 12. |
Schmidt DR, Sobota AE.
An examination of the anti-adherence activity of cranberry juice on urinary and non-urinary bacterial isolates.
Microbios
1988;
55:
173-181 |
| 13. |
Zafriri D, Ofek I, Adar R, Pocino M, Sharon N.
Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells.
Antimicrob Agents Chemother
1989;
33:
92-98 |
| 14. |
Ahuja S, Kaack B, Roberts J.
Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of P-fimbriated Escherichia coli.
J Urol
1998;
159:
559-562 |
| 15. |
Sobota AE.
Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections.
J Urol
1984;
131:
1013-1016 |
| 16. |
Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N.
Anti-Escherichia coli adhesin activity of cranberry and blueberry juices.
N Engl J Med
1991;
324:
1599 |
| 17. |
Saxelin M, Pessi T, Salminen S.
Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers.
Int J Food Microbiol
1995;
25:
199-203 |
| 18. |
Raz R, Stamm WE.
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
N Engl J Med
1993;
329:
753-756 |
(Accepted 23 March 2001)
Read all Rapid Responses